Vaccines

11 Sep 2007 Nventa initiates HspE7 Phase 1 Cervical Dysplasia Trial
08 Sep 2007 MedImmune Resolves FDA Observations Regarding Manufacturing Process for FluMist(R)
07 Sep 2007 Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
07 Sep 2007 Introgen's p53 Immunotherapy Drug Candidate to Advance Into Second Phase 2 Clinical Trial in Small Cell Lung Cancer With National Cancer Institute
06 Sep 2007 Merck: Stimuvax(R) Therapeutic Cancer Vaccine - Phase II Data Highlight Three-Year Survival Results for Lung Cancer Patients
06 Sep 2007 Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
04 Sep 2007 FDA Approves ACAM2000(TM) Vaccine for Protection against Smallpox
31 Aug 2007 Meridian Bioscience, Inc. Announces the Commencement of Phase I/II Clinical Trials of Parvovirus B19 Vaccine
29 Aug 2007 Vical Begins Phase 1 Trial of DNA Vaccine Against H5N1 Pandemic Influenza
28 Aug 2007 Immutep Announces That ImmuFact(R) IMP321 Has Entered a Phase I Lymphodepletion Therapeutic Vaccine Trial in Metastatic Melanoma
24 Aug 2007 Encouraging Phase II data on HIV vaccine utilizing GenVec technologies presented at Seattle AIDS conference
23 Aug 2007 Achievement in the Development of Hepatitis C Virus Vaccine
22 Aug 2007 Targeted Genetics reports interim Phase II data from HIV/AIDS vaccine clinical trial
21 Aug 2007 NasVax receives Ministry of Health approval for a Phase 1/2a clinical study for improved flu vaccine
21 Aug 2007 Intercell's therapeutic Hepatitis C vaccine meets primary endpoints in Phase II interim analysis
18 Aug 2007 Dendreon announces publication of Phase 1 study highlighting immunologic and clinical activity of Lapuleucel-T (Neuvenge(R)) in advanced breast cancer patients
16 Aug 2007 VGX Pharmaceuticals Announces Initiation of IND-enabling Toxicology Studies
15 Aug 2007 Sinovac Commences Vaccination of Volunteers for the Clinical Research of Pandemic Influenza Vaccine (H5N1)
15 Aug 2007 Application for Rotarix(R) by AVANT's partner, GlaxoSmithKline, is accepted for review by the FDA
10 Aug 2007 Iomai trial shows 100 percent immune response in elderly subjects vaccinated with novel travelers' diarrhea patch vaccine
09 Aug 2007 MOLOGEN AG: Treatment permission granted for cancer therapy in India
09 Aug 2007 Biomira and Merck KGaA sign amended and restated collaboration and supply agreements related to Stimuvax(R)
05 Aug 2007 ImmunoCellular Therapeutics Updates Brain Tumor Vaccine Program Status; First Three Patients Enrolled
02 Aug 2007 Iomai Vaccine Confers Statistically Significant Protection Against Travelers' Diarrhea in Phase 2 Study
01 Aug 2007 Novavax Begins Human Clinical Testing of Novel Pandemic Flu Vaccine

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up

Top